Find information on thousands of medical conditions and prescription drugs.

Fenfluramine

Fenfluramine is a drug that was part of the Fen-Phen anti-obesity medication (the other drug being phentermine). Also known as Pondimin, fenfluramine was introduced on the U.S. market in 1973. It is designed to increase the level of the neurotransmitter serotonin. This depresses the central nervous system, regulating mood and appetite. The end result is a feeling of fullness and loss of appetite.

The drug was withdrawn from the U.S. market in 1997 after reports of heart valve disease and pulmonary hypertension.

A

B

C

D

E

F

Fludrocortisone

Fluorometholone

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Dispensing with the Truth $0.29			A primer on fen-phen litigation: allegations and defenses. : An article from: Defense Counsel Journal $5.95

		Fen-phen and Redux: a tale of three drugs. : An article from: Trial $5.95


	The fen-phen summer: weight loss brings unexpected results - weight-loss drugs fenfluramine-phentermine A communicator at the Mayo Clinic in Rochester, MN, narrates her experiences about communicating to the public the results of a study which revealed an ... From Communication World, 4/1/98 by Shelly Plutowski

	Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, The Food and Drug Admin had received 144 reports of valvulopathy associated with the appetite suppressants fenfluramine and dexfenfluramine as of Sep 30, ... From Morbidity and Mortality Weekly Report, 11/14/97

	FDA warning on Chinese diet pills containing fenfluramine - Updates - Food and Drug Administration - Brief Article The FDA is alerting the public about Chinese weight-loss products, Chaso (Jianfei) Diet Capsules and Chaso Genpi, because they pose a potential public ... From FDA Consumer, 9/1/02

	Primary pulmonary hypertension associated with the use of fenfluramine derivatives - Brenot Memorial Symposium on the Pathogenesis of Primary Pulmonary Fenfluramine derivatives (Fds) are a well-established risk factor for primary pulmonary hypertension (PPH). We compared 62 Fd-PPH patients (61 women) evaluated in our center between 1986 and 1997 wit From CHEST, 9/1/98 by Gerald Simonneau

	Weight loss pills linked to lung ailment - fenfluramine-derived drugs linked to increase risk of pulmonary hypertension People who take fenfluramine-derived drugs, such as the diet drug dexfenfluramine, for at least 3 months increase their risk of developing pulmonary hypertension ... From Science News, 8/31/96 by Steve Sternberg

	Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine A 36-year-old woman (height, 157 cm; weight, 117 kg; body mass index, 47.5) received fenfluramine and phentermine (fen-phen) for 7 months, and pulmonary ... From CHEST, 2/1/02 by Tatsuo Tomita

	Medical exams advised for some diet drug users - federal authorities' advice to former users of fenfluramine and dexfenfluramine - Brief Article The federal government is advising people who took the weight-loss drugs fenfluramine (Pondimin) and dexfenfluramine (Redux) to see their doctors and, ... From FDA Consumer, 3/1/98

	Aortic and mitral fenfluramine-phentermine valulopathy in 64 patients treated with anorectic agents Context.-Few published studies of the pathology of fenfluramine-phentermine (fen-phen) valvulopathy, described by Connolly and colleagues in 1997, have ... From Archives of Pathology & Laboratory Medicine, 12/1/01 by Volmar, Keith E

Home

Contact

Resources

ebay